News & Updates

Treatment with delgocitinib ointment, a topical Janus kinase (JAK) inhibitor, for paediatric atopic dermatitis (AD) is effective and well tolerated when applied for up to 56 weeks, according to a phase III trial and a subsequent open-label, long-term study in Japan.

Supplementation with cocoa extract appears to be protective against the development of hypertension among older adults with normal systolic blood pressure (SBP) levels, but not among those with elevated SBP, as shown by the results of COSMOS* presented at EPI Lifestyle 2025.